Percutaneous coronary interventional strategies for treatment of in-stent restenosis: A network meta-analysis

The Lancet

Volumn 386, Issue 9994, 2015, Pages 655-664

  Siontis, George C M ^a   Stefanini, Giulio G ^a,b   Mavridis, Dimitris ^c   Siontis, Konstantinos C ^d   Alfonso, Fernando ^e   Pérez Vizcayno, María J ^f   Byrne, Robert A ^g,h   Kastrati, Adnan ^g,h   Meier, Bernhard ^a   Salanti, Georgia ^c   Jüni, Peter ⁱ   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF IOANNINA   (Greece)

^d MAYO CLINIC   (United States)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

ⁱ UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTICLE; BARE METAL STENT; BRACHYTHERAPY; COMPARATIVE EFFECTIVENESS; EVEROLIMUS ELUTING CORONARY STENT; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; META ANALYSIS; PACLITAXEL ELUTING CORONARY STENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROTATIONAL ATHERECTOMY; ROTATIONAL ATHERECTOMY DEVICE; SIROLIMUS ELUTING CORONARY STENT; SYSTEMATIC REVIEW; VASCULAR BRACHYTHERAPY; ANALOGS AND DERIVATIVES; CORONARY RESTENOSIS; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; PROCEDURES; STENT; TREATMENT OUTCOME;

EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 84939458843     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60657-2     Document Type: Article

References (77)

1. A Kastrati, J Mehilli, J Pache et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
2. C Stettler, S Wandel, S Allemann et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
3. GG Stefanini, U Baber, S Windecker et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials Lancet 382 2013 1879 1888
4. T Palmerini, G Biondi-Zoccai, D Della Riva et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
5. M Taniwaki, GG Stefanini, S Silber for the RESOLUTE All-Comers Investigators 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention) J Am Coll Cardiol 63 2014 1617 1625
6. S Cassese, RA Byrne, T Tada et al. Incidence and predictors of restenosis after coronary stenting in 10-004 patients with surveillance angiography Heart 100 2014 153 159
7. AS Go, D Mozaffarian, VL Roger for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
8. F Alfonso, RA Byrne, F Rivero, A Kastrati Current treatment of in-stent restenosis J Am Coll Cardiol 63 2014 2659 2673
9. JP Higgins, DG Altman, PC Gøtzsche for the Cochrane Bias Methods Group the Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
10. R DerSimonian, N Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
11. J Cohen Statistical power analysis for the behavioral sciences 2nd edn. 1988 Lawrence Erlbaum Associates Hillsdale
12. A Cipriani, JP Higgins, JR Geddes, G Salanti Conceptual and technical challenges in network meta-analysis Ann Intern Med 159 2013 130 137
13. DM Caldwell, AE Ades, JP Higgins Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 2005 897 900
14. G Lu, AE Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 2004 3105 3124
15. A Chaimani, JP Higgins, D Mavridis, P Spyridonos, G Salanti Graphical tools for network meta-analysis in STATA PLoS One 8 2013 e76654
16. IR White Multivariate random-effects meta-regression: updates to mvmeta Stata J 11 2011 255 270
17. IR White, JK Barrett, D Jackson, JP Higgins Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression Res Synth Methods 3 2012 111 125
18. G Salanti, AE Ades, JP Ioannidis Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial J Clin Epidemiol 64 2011 163 171
19. RM Turner, J Davey, MJ Clarke, SG Thompson, JP Higgins Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews Int J Epidemiol 41 2012 818 827
20. HC Bucher, GH Guyatt, LE Griffith, SD Walter The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 1997 683 691
21. AA Veroniki, HS Vasiliadis, JP Higgins, G Salanti Evaluation of inconsistency in networks of interventions Int J Epidemiol 42 2013 332 345
22. S Dias, NJ Welton, DM Caldwell, AE Ades Checking consistency in mixed treatment comparison meta-analysis Stat Med 29 2010 932 944
23. JP Higgins, D Jackson, JK Barrett, G Lu, AE Ades, IR White Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies Res Synth Methods 3 2012 98 110
24. A Booth, M Clarke, D Ghersi, D Moher, M Petticrew, L Stewart An international registry of systematic-review protocols Lancet 377 2011 108 109
25. MB Leon, PS Teirstein, JW Moses et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N Engl J Med 344 2001 250 256
26. JJ Popma, M Suntharalingam, AJ Lansky for the Stents And Radiation Therapy (START) Investigators Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis Circulation 106 2002 1090 1096
27. S Silber, JJ Popma, M Suntharalingam for the START Investigators Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis Am Heart J 149 2005 689 694
28. K Reynen, J Kropp, U Köckeritz et al. Intracoronary radiotherapy with a 188Rhenium liquid-filled angioplasty balloon system in in-stent restenosis: a single-center, prospective, randomized, placebo-controlled, double-blind evaluation Coron Artery Dis 17 2006 371 377
29. J vom Dahl, U Dietz, PK Haager et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST) Circulation 105 2002 583 588
30. U Dietz, HJ Rupprecht, MA de Belder et al. Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST) Am J Cardiol 90 2002 843 847
31. PK Haager, F Schiele, HJ Buettner for the ARTIST Investigators Insufficient tissue ablation by rotational atherectomy leads to worse long-term results in comparison with balloon angioplasty alone for the treatment of diffuse in-stent restenosis: insights from the intravascular ultrasound substudy of the ARTIST randomized multicenter trial Catheter Cardiovasc Interv 60 2003 25 31
32. SK Sharma, A Kini, R Mehran, A Lansky, Y Kobayashi, JD Marmur Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER) Am Heart J 147 2004 16 22
33. F Alfonso, J Zueco, A Cequier for the Restenosis Intra-stent: Balloon Angioplasty Versus Elective Stenting (RIBS) Investigators A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis J Am Coll Cardiol 42 2003 796 805
34. F Alfonso, R Melgares, V Mainar for the Restensois Intra-stent: Ballon Angioplasty Versus Elective Stenting (RIBS) Investigators Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the Restenosis Intra-stent Balloon Angioplasty Versus Elective Stenting (RIBS) randomized trial Eur Heart J 25 2004 1829 1835
35. F Alfonso, JM Augé, J Zueco for the RIBS Investigators Long-term results (three to five years) of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Stenting (RIBS) randomized study J Am Coll Cardiol 46 2005 756 760
36. M Ragosta, H Samady, LW Gimple, IJ Sarembock, M Fenster, ER Powers Percutaneous treatment of focal vs diffuse in-stent restenosis: a prospective randomized comparison of conventional therapies Catheter Cardiovasc Interv 61 2004 344 349
37. F Alfonso, P García, H Fleites et al. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study Am Heart J 149 2005 e1 e8
38. A Kastrati, J Mehilli, N von Beckerath for the ISAR-DESIRE Study Investigators Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
39. F Alfonso, MJ Pérez-Vizcayno, R Hernandez for the RIBS-II Investigators A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J Am Coll Cardiol 47 2006 2152 2160
40. F Alfonso, MJ Pérez-Vizcayno, R Hernández for the RIBS-II Investigators Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. Elective Sirolimus-eluting Stenting) study J Am Coll Cardiol 52 2008 1621 1627
41. DR Holmes Jr, P Teirstein, L Satler for the SISR Investigators Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial JAMA 295 2006 1264 1273
42. DR Holmes Jr, PS Teirstein, L Satler for the SISR Investigators 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-stent Restenosis) trial JACC Cardiovasc Interv 1 2008 439 448
43. OO Alli, PS Teirstein, L Satler for the SISR Investigators Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-stent Restenosis (SISR) trial Am Heart J 163 2012 438 445
44. GW Stone, SG Ellis, CD O'Shaughnessy for the TAXUS V ISR Investigators Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
45. SG Ellis, CD O'Shaughnessy, SL Martin for the TAXUS V ISR Investigators Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial Eur Heart J 29 2008 1625 1634
46. C Schukro, B Syeda, C Kirisits et al. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis Radiother Oncol 82 2007 18 23
47. SW Park, SW Lee, BK Koo et al. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED study Int J Cardiol 131 2008 70 77
48. J Mehilli, RA Byrne, K Tiroch for the ISAR-DESIRE 2 Investigators Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
49. B Chevalier, R Moulichon, E Teiger for the Cristal Investigators One-year results of the CRISTAL trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents J Interv Cardiol 25 2012 586 595
50. HG Song, DW Park, YH Kim et al. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation J Am Coll Cardiol 59 2012 1093 1100
51. F Alfonso, MJ Pérez-Vizcayno, A Cárdenas for the RIBS V Study Investigators under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V clinical trial (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs. Everolimus-eluting Stent) J Am Coll Cardiol 63 2014 1378 1386
52. F Alfonso, MJ Pérez-Vizcayno, A Cárdenas for the RIBS IV Study Investigators (under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology) A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial J Am Coll Cardiol 66 2015 23 33
53. B Scheller, C Hehrlein, W Bocksch et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
54. B Scheller, C Hehrlein, W Bocksch et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
55. B Scheller, YP Clever, B Kelsch et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter JACC Cardiovasc Interv 5 2012 323 330
56. M Unverdorben, C Vallbracht, B Cremers et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
57. S Habara, K Mitsudo, K Kadota et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis JACC Cardiovasc Interv 4 2011 149 154
58. H Rittger, J Brachmann, AM Sinha et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
59. S Habara, M Iwabuchi, N Inoue et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis Am Heart J 166 2013 527 533
60. RA Byrne, FJ Neumann, J Mehilli for the ISAR-DESIRE 3 investigators Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
61. B Xu, R Gao, J Wang for the PEPCAD China ISR Trial Investigators A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial JACC Cardiovasc Interv 7 2014 204 211
62. G Salanti, C Del Giovane, A Chaimani, DM Caldwell, JP Higgins Evaluating the quality of evidence from a network meta-analysis PLoS One 9 2014 e99682
63. Authors/Task Force members S Windecker, P Kolh et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 35 2014 2541 2619
64. GG Stefanini, DR Holmes Jr Drug-eluting coronary-artery stents N Engl J Med 368 2013 254 265
65. L Räber, M Magro, GG Stefanini et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study Circulation 125 2012 1110 1121
66. S Bangalore, S Kumar, M Fusaro et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117-762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
67. T Pilgrim, D Heg, M Roffi et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial Lancet 384 2014 2111 2122
68. G Richardt, M Leschke, M Abdel-Wahab for the RESOLUTE All Comers the RESOLUTE International Investigators Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis JACC Cardiovasc Interv 6 2013 905 913
69. PC Smits, S Hofma, M Togni et al. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial Lancet 381 2013 651 660
70. S Silber, S Windecker, P Vranckx, PW Serruys for the RESOLUTE All Comers Investigators Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Lancet 377 2011 1241 1247
71. RA Byrne, M Joner, F Alfonso, A Kastrati Drug-coated balloon therapy in coronary and peripheral artery disease Nat Rev Cardiol 11 2014 13 23
72. B Scheller, U Speck, C Abramjuk, U Bernhardt, M Böhm, G Nickenig Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814
73. R Piccolo, G Galasso, F Piscione et al. Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis Am J Cardiol 114 2014 1339 1346
74. JM Lee, J Park, J Kang et al. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials JACC Cardiovasc Interv 8 2015 382 394
75. G Campo, M Tebaldi, P Vranckx et al. Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) J Am Coll Cardiol 63 2014 506 512
76. EJ Mills, K Thorlund, JP Ioannidis Demystifying trial networks and network meta-analysis BMJ 346 2013 f2914
77. SJ Kang, GS Mintz, DW Park et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis Circ Cardiovasc Interv 4 2011 9 14